These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29535531)

  • 1. Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis.
    Tang L; Li J; Bao M; Xiang J; Chen Y; Wang Y
    Onco Targets Ther; 2018; 11():1055-1066. PubMed ID: 29535531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the epidemiological and prognosis significance of ESR2 rs3020450 polymorphism in ovarian cancer.
    Feng Y; Peng Z; Liu W; Yang Z; Shang J; Cui L; Duan F
    Gene; 2019 Aug; 710():316-323. PubMed ID: 31200086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Causes Control; 2009 Feb; 20(1):47-55. PubMed ID: 18704709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ESR1 and ESR2 Polymorphisms with Osteoporosis: A Meta-Analysis from 36 Studies.
    Ren H; Liu H; Huang L; Xie W; Lin D; Luo D
    J Clin Densitom; 2022; 25(4):699-711. PubMed ID: 36175246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study.
    Sghaier I; Zidi S; El-Ghali RM; Daldoul A; Aimagambetova G; Almawi WY
    Gene; 2023 Jan; 851():146969. PubMed ID: 36261089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between melatonin receptor gene polymorphisms and polycystic ovarian syndrome: a systematic review and meta-analysis.
    Yi S; Xu J; Shi H; Li W; Li Q; Sun YP
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32463080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.
    Gao Z; Fu HJ; Xue JJ; Wu ZX; Zhao LB
    Mol Biol Rep; 2014 Jul; 41(7):4463-74. PubMed ID: 24595449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AGT Haplotype of the ESR2 Gene Containing the Polymorphisms rs2077647A, rs4986938G, and rs1256049T Increases the Susceptibility of Unexplained Recurrent Spontaneous Abortion in Women in the Chinese Hui Population.
    Tang D; Bao J; Bai G; Hao M; Jin R; Liu F
    Med Sci Monit; 2020 May; 26():e921102. PubMed ID: 32359133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Estrogen Receptor Genes Polymorphisms With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Based on Observational Studies.
    Zhou S; Wen S; Sheng Y; Yang M; Shen X; Chen Y; Kang D; Xu L
    Front Endocrinol (Lausanne); 2021; 12():726184. PubMed ID: 34671317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Association between Estrogen Receptor-Β Rs4986938 and Cancer Risk: A Systematic Review and Meta-Analysis.
    Li Z; Yang X; Zhang R; Zhang D; Li B; Zhang D; Li Q; Xiong Y
    Iran J Public Health; 2019 May; 48(5):784-795. PubMed ID: 31523634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).
    Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
    Cancer Causes Control; 2004 Aug; 15(6):627-33. PubMed ID: 15280642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of estrogen receptor-beta (ESR2) polymorphism and cancer risk: a meta-analysis.
    Xia W; Wang T; Sun D; Mao W; Xie X
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):530-538. PubMed ID: 29894079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between non-coding RNAs genetic polymorphisms with ovarian cancer risk: A systematic review and meta-analysis update with trial sequential analysis.
    Liu H; Sun L; Liu X; Wang R; Luo Q
    Medicine (Baltimore); 2023 Sep; 102(39):e35257. PubMed ID: 37773807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.
    Pu D; Jiang SW; Wu J
    Curr Pharm Des; 2014; 20(11):1632-8. PubMed ID: 24720627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
    Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O
    Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein Lipase Gene Polymorphisms Are Associated with Myocardial Infarction Risk: A Meta-Analysis.
    He K; Zhu Z; Chen Y
    Genet Test Mol Biomarkers; 2021 Jun; 25(6):434-444. PubMed ID: 34152845
    [No Abstract]   [Full Text] [Related]  

  • 17. E-selectin gene polymorphisms and essential hypertension in Asian population: an updated meta-analysis.
    Cai G; Zhang B; Weng W; Shi G; Xue S; Song Y; Ma C
    PLoS One; 2014; 9(7):e102058. PubMed ID: 25003340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the ESR1 and ESR2 polymorphisms and osteoporosis risk: An updated meta-analysis.
    Bai XH; Su J; Mu YY; Zhang XQ; Li HZ; He XF; He XF
    Medicine (Baltimore); 2023 Oct; 102(41):e35461. PubMed ID: 37832086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.
    Chang X; Wang H; Yang Z; Wang Y; Li J; Han Z
    Medicine (Baltimore); 2023 Jun; 102(23):e33937. PubMed ID: 37335680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: A meta-analysis.
    Liu M; Zhu W; Wang J; Zhang J; Guo X; Wang J; Song J; Dong W
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):516-25. PubMed ID: 25497273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.